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Context: Insulin-like 3 and its receptor, leucine-rich repeat-containing G protein-coupled receptor 8
(LGR8),areessential forthefirstphaseoftesticulardescent.Homozygous lossofeitherofthetwogenes
in mice leads to cryptorchidism. Although mutations in both homologous human genes are not a
common cause of cryptorchidism. To date, only one missense mutation at codon 222 (T222P) of the
LGR8 gene has been proposed as a causative mutation for cryptorchidism. This conclusion was based
on both functional in vitro studies and the lack of mutation in a large group of controls. The geo-
graphical origin of the mutation carriers suggested a founder effect in the Mediterranean area.
Objectives:We sought to define the frequency of the T222P mutation in four different countries
to assess whether the screening for this mutation could be of use as a diagnostic genetic test.
Materials and Methods: A total of 822 subjects (359 with a history of cryptorchidism and 463
controls) from Italy, Spain, Hungary, and Egypt were genotyped for the T222P mutation by direct
sequencing.
Results: The phenotypical expression of themutation also included normal testicular descent. The
mutation frequency was not significantly different in cryptorchid patients vs. noncryptorchid con-
trols (3.6vs. 1.7%, respectively).No significantgeographicaldifferenceswereobserved inmutation
frequencies. The haplotype analysis allowed us to predict three distinct haplotypes, i.e. three
possible mutation events.
Conclusions:Our results suggest that the T222Pmutation cannot be considered either causative or
a susceptibility factor for cryptorchidism. A true causative mutation in the LGR8 gene still remains
to be identified. (J Clin Endocrinol Metab 93: 1072–1076, 2008)
Cryptorchidism is the most common congenital malforma-tion in newborn boys (1–9%) andmayoccur as an isolated
anomaly or may be associated with other congenital disorders
(1). The etiology of the majority of nonsyndromic (isolated)
cryptorchidism remains unknown, but many risk factors, both
environmental and genetic, have been proposed (1–3).
Testicular descent requires the action of twomajor hormonal
factors: insulin-like 3 (INSL3) and androgens. INSL3 and its
receptor, the leucine-rich repeat-containing G protein-coupled
receptor 8 (LGR8), recently renamed relaxin family peptide re-
ceptor 2 (4), are essential for the first phase (transabdominal) of
descent, whereas androgens (mainly testosterone) and the an-
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drogen receptor act principally during the second (inguinoscro-
tal) phase (5). Any factor or genetic anomaly influencing these
two hormone receptor systemsmay lead to cryptorchidism. Cer-
tain androgen receptor gene mutations in human are associated
with cryptorchidism, but in these cases, other symptoms of an-
drogen deficiency are also present (6). The first evidence sup-
porting the importance of the INSL3/LGR8 system derives from
animal models. Knockout mutant mice for either Insl3 (7, 8) or
Lgr8 (9, 10) are cryptorchid, and the overexpression of Insl3 in
the female mouse induces ovarian descent (11, 12). Moreover,
Lgr8 is highly expressed in the gubernaculum, the ligament that
controls testicular position during development, and the guber-
nacula of the mutant males fail to differentiate. Despite this,
mutations in both homologous human genes are not a common
cause of cryptorchidism in patients. Since the first mutation
screening of the INSL3 gene in cryptorchid men (13), a large
number of polymorphisms and putative mutations were de-
scribed (5, 14).Of all reportedmutations, only twomissense, the
P49SandV18M,mutationshadadeleterious effect on the ability
of INSL3 to activate its receptor (15, 16). However, the role of
these mutations (all heterozygous) in the pathogenesis of cryp-
torchidism remains to be established. The screening for LGR8
mutations was also relatively disappointing because apart from
a few genetic variants with no clear pathogenic effect, only one
putative causativemissensemutation at codon 222 (T222P) was
described in subjects from Southern Europe (9, 17). All patients
were heterozygous for the mutation and presented a variable
phenotype of testicular maldescent. Because the haplotype anal-
ysis indicated a common origin of thismutation, a founder effect
in the Mediterranean area was postulated. Functional studies
showed a severely reduced receptor surface expression of the
mutant protein supporting its causative role in the pathogenesis
of cryptorchidism (18). The functional data, together with the
lack of the T222Pmutation in 450 controls from Italy, led to the
conclusion of an exclusive association of this mutation with
cryptorchidism. Based on the aforementioned conclusion,
Bogatcheva et al. (18) suggested that the recognition of such
patients would permit family screening and potential early ther-
apeutic intervention.
The aim of the present study was to evaluate the frequency of
the T222P mutation in four different countries (Italy, Spain,
Hungary, and Egypt), both for clinical purposes and for gaining
further insight into the origin of this “Mediterranean”mutation.
Patients and Methods
A total of 822 subjects from four different countries were analyzed for
the T222P mutation. Among them 359 patients had a history of cryp-
torchidism, whereas the remaining 463 were controls with no history of
testicular maldescent at birth. The geographical distributionwas: 1) 159
patients of Italian origin (n  98 unilateral, n  61 bilateral) attending
the Andrology Unit of the University Hospital Careggi (Florence) and
from the Endocrinology Unit of the University of Ancona; 2) 70 Hun-
garian patients (n 51 unilateral, n 19 bilateral) from the Andrology
Division of the National Health Center of Budapest; 3) 53 patients of
Egyptian origin (n  45 unilateral, n  8 bilateral) from the Kamal
Hospital; and 4) 77 Spanish patients from the Fundacio Puigvert (Bar-
celona). The controls, without a history of cryptorchidism at birth, i.e.
also excluding late spontaneous descent or retractile testis, were: 1)
groupA, 312patients (144 Italian, 120Hungarian, and48 Spanish)with
reduced sperm count from infertile couples; and 2) group B, 151 (131
Italian, 20Hungarian)withnormal spermparameters.Written informed
consent was obtained from all patients and controls included in the
present study. The institutional review boards of referral centers have
approved this protocol.
Genotyping
The sequences of the primers used for the amplification of exon 8
containing the T222P mutation were: forward, 5-GGGGAGGCAG-
GTTTTATTTC-3; and reverse, 5-AAGCTAGTGCTAGATGTCAT-
TGC-3. The resultingDNA fragmentswere sequenced using automated
sequencer (ABI PRISM 310; Applied Biosystems, Foster City, CA).
Haplotype analysis
A total of five polymorphisms were analyzed in 19 carriers of the
T222P mutation. For the analysis of exon 12-intron 12 polymorphisms
[exon 12: 957GA, 993AG; intron 12: INV12(-2)A9A13], the prim-
ers are described by Ferlin et al. (17). Primers for the intron 7
[INV7(351)AC] and intron 9 polymorphisms [INV9(380)AC]
were as follows: forward, 5-ATCAGTTTAACACCATGTGACCAAA-
3; reverse, 5-GGGTACCTGGGTCTGGCAC-3; and forward, 5-
CCCTAAGCATATTGTTCCTTGGA-3; reverse, 5-GGGAGTACAT-
AGGTGGCTGCTG-3. The resulting DNA fragments were sequenced
using automated sequencer (ABI PRISM 310).
Statistical analysis
Statistical analysis was performed using SSPS software (SPSS, Inc.,
Chicago, IL). Genotype and allele frequencies were analyzed by the 2
test. Between-group comparisons for semen parameters were performed
by theMann-WhitneyU test for unpaired data. A P value less than 0.05
was considered statistically significant.
Results
Mutation analysis of exon 8 of the LGR8 gene
The LGR8mutation analysis was performed in 822 subjects
from three Mediterranean and one Central European country.
The composition of the study population is reported in Table 1.
The T222P mutation was found in both cryptorchid and non-
cryptorchid subjects. The frequency observed in the cryptorchid
group (n  359) was 3.6%, which is not significantly different
from the 1.7% in 463 controls (groups A and B). The mutation
frequencies in different subgroups of controls and patients based
on their ethnic background are reported in Table 1. The highest
mutation frequency among cryptorchids was found in the Egyp-
tian population (5.66%), followed by the Italian (5.03%) and
Hungarian (2.86%). No mutation was found in the Spanish
cryptorchids. In the control groups, we found the highest fre-
quency in theSpanishpopulation (4.17%) (likelydue to the small
sample size), followed by Italians (1.82%) and Hungarians
(0.71%). Although Hungarians showed a relatively low fre-
quency, the difference was not significant in comparison with
other countries. Finally, to define whether the T222P mutation
can be considered a risk factor in a specific ethnic group, we
compared the mutation frequencies between cryptorchids and
noncryptorchids for each country. The observed differences
were not statistically significant in any of the examined
populations.
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Genotype/phenotype correlation
In all 21 cases, themutationwasheterozygous.Analysis of the
parent’s DNA was possible only in one patient, and the mother
resulted a heterozygous carrier. The brother of patient A251 had
a history of bilateral cryptorchidism as well. The phenotypical
expression of this mutation in our multiethnic study population
also includes normal testicular descent in eight cases from three
different countries. These data exclude a causative association
between the mutation and cryptorchidism. The testicular phe-
notype of the 13 cryptorchid patients was variable: seven had a
history of unilateral and six of bilateral cryptorchidism. In all
cases orchidopexy was performed during infancy. The sperm
concentration of the cryptorchid mutation carriers ranged from
azoospermia to 11million spermatozoa permilliliter, whereas in
the noncryptorchids from 0.9–75 million spermatozoa per mil-
liliter. No significant difference was found in the mean sperm
concentration and total sperm count between cryptorchid men
with andwithout mutation. The frequency of the T222Pmutation
in thenoncryptorchid controlswas similar, regardlessof the level of
sperm production: 1.9% in patients with impaired sperm produc-
tion (group A) vs. 1.3% in normozoospermic men (group B).
LGR8 gene haplotyping
The analysis of five exonic and intronic polymorphisms in 19
carriers allowed the discrimination of different possible haplo-
types (Table 2). The majority of patients and controls (n  16)
presented a common inferred haplotype: C-C-G-A-13. Two
Hungarian cryptorchid men (HU85, HU89) were lacking this
specific haplotype due to a different length of the polyadenine
stretch. These two men share the C-C-G-A-10 haplotype that
may also derive from the commonC-C-G-A-13 through the con-
traction of the polyadenine stretch. Finally, one control patient
of Italian origin (A448) resulted homozygous for the INV9
(380) marker (AA), consequently, his inferred haplotypes are
as follows:C-A-G-A-13andC-A-G-A-10.TheC-A-G-A-13hap-
lotype is also shared by seven other patients. According to our
results, the mutation must have occurred on at least two (or
three) independent occasions.
Discussion
Since the first description of the T222P mutation of the LGR8
gene, a clear-cut cause-effect relationship was evoked between
the mutation and cryptorchidism (9, 17, 18). This conclusion
was based on the lack of this mutation in a relatively large group
(n  643) of unaffected controls from Italy, the United States,
and France. Given that all mutations in humans were heterozy-
gous, whereas cryptorchidism was observed exclusively in ho-
mozygous knockout Lgr8 mice, a number of hypotheses were
proposed to explain this contrast (17). The most likely among
them seemed to be haploinsufficiency (threshold effect), i.e. the
absence of one allele is enough to cause the phenotype. Recent in
vitro functional studies demonstrated that the mutation, rather
than influencing receptor signal transduction, reduces receptor
expression on cell membranes (18). This would support the
threshold hypothesis, and also explain the wide variability rang-
ing frombilateral cryptorchidism tounilateralmaldescent and to
retractile testes. According to the first studies, the phenotypical
expressionof themutationwas restricted to cryptorchidism, also
in the last largest study in which no mutation was found in 450
Italian controls (18). This figure is in sharp contrast with our
finding of a total of eight carriers of 463 noncryptorchid men
(eight of 463 vs. zero of 450; P  0.01) and remains highly
significant, even if we restrict the comparison to the Italian con-
trols (five of 275 vs. zero of 450; P  0.01). The relatively high
frequency of the mutation (1%, with the exception of Hun-
gary) in men without a history of cryptorchidism or retractile
testes indicates that the T222P mutation is more likely to be a
polymorphism in these countries rather than a causative muta-
tion. Because a mild functional effect was reported in in vitro
studies, it is still possible that only homozygous T222Pmutation
(not yet found) is associated with abnormal testis descent. It is in-
triguingthat themutation isalsoabsent ina totalof139cryptorchid
and 286 control subjects from Germany, France, Finland, the
United States, and Japan (9, 19–21). Thiswould support the initial
hypothesis of a founder effect in theMediterraneanarea.However,
the presence of themutation in a central Europeanpopulation such
as Hungary, together with the haplotype analysis, questions the
existence of a unique commonancestor.Our analysis indicates that
themutationoccurredat least twice (more likely three times)during
human history. However, an alternative explanation could be that
recurrent mutation at the INV9 (380) position converting
CCGA13 toCAGA13 or gene conversion producing local changes
to thehaplotypesmayhaveoccurred, and, thus, themutationshave
originated in one single individual.
The original aim of our studywas to define the frequency of the
T222P mutation of the LGR8 gene, the only known “causative”
mutation fornonsyndromic cryptorchidism, in fourdifferent coun-
tries, to assess whether the screening for this mutation could be of
use as a diagnostic genetic test. Although the frequencywe found in
TABLE 1. T222P LGR8 mutation in patients with a history of
testicular maldescent and in controls with no history of
cryptorchidism, or retractile testes or late spontaneous descent
No. of mutated/
no. of total men
T222P mutation
frequency (%)
Cryptorchid (n  359)
Italians 8/159 5.03
Hungarians 2/70 2.86
Spanish 0/77 0
Egyptians 3/53 5.66
Total 13/359 3.6
Noncryptorchid (n  463)
Italians (n  275)
Group A 2/131 1.52
Group B 3/144 2.08
Hungarians (n  140)
Group A 0/20 0
Group B 1/120 0.83
Spanish (n  48)
Group B 2/48 4.17
Total 8/463 1.7
The non cryptorchid control group includes group A, which contains patients
with reduced sperm count referred for couple infertility, and group B, which
contains men with normal sperm parameters.
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the cryptorchid groups is similar to that of Ferlin et al. (17), our
results also suggest that the T222Pmutation cannot be considered
either causative or a susceptibility factor for cryptorchidism. De-
spite the well-established role of the INSL3/LGR8 system in the
regulation of testicular descent, a true causative mutation in the
LGR8 gene still remains to be identified.
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TABLE 2. Haplotype analysis of the LGR8 gene based on five intronic (intron 7 and 9) and exonic (exon 12) polymorphisms
Code
Polymorphisms
Possible haplotypes
INV7
(351) A>C
INV9
(380) A>C
Exon 12 SNPs
957G>A 993A>G
Intron 12
INV12 (-2)A9>A13
Italian
Cryptorchid
MMP 122 AC AC GG AA 12/13 AAGA12/ACGA12/CAGA12/CCGA12
AAGA13/ACGA13/CAGA13/CCGA13
MMP 299 AC CC GG AA 10/13 ACGA10/CCGA10/ACGA13/CCGA13
MMP 475 AC AC GG AA 12/13 AAGA12/ACGA12/CAGA12/CCGA12
AAGA13/ACGA13/CAGA13/CCGA13
A191 AC CC GG AA 10/13 ACGA10/CCGA10/ACGA13/CCGA13
A 251 CC CC GA AA 12/13 CCGA12/CCAA12/CCGA13/CCAA13
A639 AC CC GG AA 10/13 ACGA10/CCGA10/ACGA13/CCGA13
CH 4 AC CC GA AA 10/13 ACGA10/CCGA10/ACAA10/CCAA10
ACGA13/CCGA13/ACAA13/CCAA13
CH 16 AC AC GG AA 12/13 AAGA12/ACGA12/CAGA12/CCGA12
AAGA13/ACGA13/CAGA13/CCGA13
Control 1
A268 AC CC GG AA 11/13 ACGA11/CCGA11/ACGA13/CCGA13
A337 AC CC GG AA 10/13 ACGA10/CCGA10/ACGA13/CCGA13
A448 CC AA GG AA 10/13 CAGA10/CAGA13
Control 2
CS32 CC AC GG GA 11/13 CAGG11/CCGG11/CAGA11/CCGA11
CAGG13/CCGG13/CAGA13/CCGA13
C68 AC AC GA AA 10/13 AAGA10/CAGA10/ACGA10/CCGA10
AAAA10/CAAA10/ACAA10/CCAA10
AAGA13/CAGA13/ACGA13/CCGA13
AAAA13/CAAA13/ACAA13/CCAA13
Hungarian
Cryptorchid
HU85 AC AC GA AA 10/12 AAGA10/ACGA10/CAGA10/CCGA10
AAAA10/ACAA10/CAAA10/CCAA10
AAGA12/ACGA12/CAGA12/CCGA12
AAAA12/ACAA12/CAAA12/CCAA12
HU89 AC AC GA AA 10/10 AAGA10/ACGA10/CAGA10/CCGA10
AAAA10/ACAA10/CAAA10/CCAA10
Control 1
HU179 AC CC GG GA 11/13 ACGG11/CCGG11/ACGA11/CCGA11
ACGG13/CCGG13/ACGA13/CCGA13
Egyptian
Cryptorchid
E630 AC CC GG AA 12/13 ACGA12/CCGA12/ACGA13/CCGA13
E371 AC AC GG AA 12/13 AAGA12/ACGA12/CAGA12/CCGA12
AAGA13/ACGA13/CAGA13/CCGA13
Spanish
Control 1
SP169 CC AC GG GA 11/13 CCGG11/CAGG11/CCGA11/CAGA11
CCGG13/CAGG13/CCGA13/CAGA13
Control 1 represents noncryptorchid patients with impaired sperm production. Control 2 represents normospermic noncryptorchid. Common inferred haplotypes are
indicated in bold. SNP, Single nucleotide polymorphism.
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